Characterizing and Risk Stratifying Musculoskeletal Toxicities after BCMA CAR-T Therapy for Relapsed/Refractory Multiple Myeloma
Publication
, Conference
Feng, A; Choi, T; Wu, J; Wang, X; Bellavia, T; Schrum, D; Eberwein, E; Cheng, S; Huggins, J; Tam, P; Kirby, S; Gasparetto, C; Costa Chase, C ...
Published in: Blood
November 5, 2024
Duke Scholars
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 5, 2024
Volume
144
Issue
Supplement 1
Start / End Page
2001 / 2001
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Feng, A., Choi, T., Wu, J., Wang, X., Bellavia, T., Schrum, D., … Kang, Y. (2024). Characterizing and Risk Stratifying Musculoskeletal Toxicities after BCMA CAR-T Therapy for Relapsed/Refractory Multiple Myeloma. In Blood (Vol. 144, pp. 2001–2001). American Society of Hematology. https://doi.org/10.1182/blood-2024-208621
Feng, Amber, Taewoong Choi, Jian Wu, Xiaobei Wang, Tanya Bellavia, Daniel Schrum, Erin Eberwein, et al. “Characterizing and Risk Stratifying Musculoskeletal Toxicities after BCMA CAR-T Therapy for Relapsed/Refractory Multiple Myeloma.” In Blood, 144:2001–2001. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-208621.
Feng A, Choi T, Wu J, Wang X, Bellavia T, Schrum D, et al. Characterizing and Risk Stratifying Musculoskeletal Toxicities after BCMA CAR-T Therapy for Relapsed/Refractory Multiple Myeloma. In: Blood. American Society of Hematology; 2024. p. 2001–2001.
Feng, Amber, et al. “Characterizing and Risk Stratifying Musculoskeletal Toxicities after BCMA CAR-T Therapy for Relapsed/Refractory Multiple Myeloma.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 2001–2001. Crossref, doi:10.1182/blood-2024-208621.
Feng A, Choi T, Wu J, Wang X, Bellavia T, Schrum D, Eberwein E, Cheng S, Huggins J, Tam P, Kirby S, Gasparetto C, Costa Chase C, Long GD, Rowe-Nichols K, Kang Y. Characterizing and Risk Stratifying Musculoskeletal Toxicities after BCMA CAR-T Therapy for Relapsed/Refractory Multiple Myeloma. Blood. American Society of Hematology; 2024. p. 2001–2001.
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 5, 2024
Volume
144
Issue
Supplement 1
Start / End Page
2001 / 2001
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology